Because we wanted to investigate the effect of changes in SOX2 expression in SCLC, the DMS114 cells with the lowest level of SOX2 expression were selected for use in further experiments of cisplatin resistance. The gene discussed is SOX2; the disease is small cell lung carcinoma.